Aprepitant Interactions
There are 453 drugs known to interact with aprepitant, along with 1 disease interaction, and 1 alcohol/food interaction. Of the total drug interactions, 75 are major, 352 are moderate, and 26 are minor.
- View all 453 medications that may interact with aprepitant
- View aprepitant alcohol/food interactions (1)
- View aprepitant disease interactions (1)
Most frequently checked interactions
View interaction reports for aprepitant and the medicines listed below.
- Activated Charcoal (charcoal)
- Adderall (amphetamine / dextroamphetamine)
- Ativan (lorazepam)
- Benadryl (diphenhydramine)
- Carafate (sucralfate)
- Claritin (loratadine)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Colace (docusate)
- Compazine (prochlorperazine)
- CoQ10 (ubiquinone)
- Demerol (meperidine)
- Dilaudid (hydromorphone)
- Eliquis (apixaban)
- EpiPen (epinephrine)
- Lyrica (pregabalin)
- Metoprolol Succinate ER (metoprolol)
- MiraLAX (polyethylene glycol 3350)
- Nurtec ODT (rimegepant)
- Paracetamol (acetaminophen)
- Pepcid (famotidine)
- Phenergan (promethazine)
- Protonix (pantoprazole)
- Tylenol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- Vyvanse (lisdexamfetamine)
- Xanax (alprazolam)
- Zofran (ondansetron)
- Zofran ODT (ondansetron)
- Zyrtec (cetirizine)
Aprepitant alcohol/food interactions
There is 1 alcohol/food interaction with aprepitant.
Aprepitant disease interactions
There is 1 disease interaction with aprepitant which include:
Report options
QR code containing a link to this page
More about aprepitant
- aprepitant consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (18)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: NK1 receptor antagonists
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
